Track the 에스디바이오센서 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 에스디바이오센서 has recorded 73 insider filings. Market capitalisation: €716.5bn. The latest transaction was reported on 24 March 2026 (Purchase). Among the most active insiders: 김석규. All data is openly available.
73
Insider Decl.
n/a
Thresholds
€2m
56 ops.
Buy Volume
n/a
12 ops.
Sell Volume
32Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,618 of 28,065 companies
38.5
score / 100
Value
50
Quality
27
FCF yld42%
Earn yld-71%
EV/EBITDA·
ROE-18%
Gross mgn46%
Net mgn-72%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Listed on the XKRX market, 에스디바이오센서 is a company specializing in the health and pharmaceutical sector. It focuses on the development and manufacturing of medical diagnostic devices.